Evaluation of the Effect of a Speech Detection Tool on the Improvement of Phonation in Neuromuscular Patients Dependent on Mechanical Ventilation
NCT ID: NCT03504514
Last Updated: 2019-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2019-11-06
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Installation of Non-invasive Ventilation at Home Using Telemedicine : a Pilot Study on Feasibility and Impact on Ventilation Compliance
NCT02103790
Early Speech With One-Way Speaking Valve in Tracheostomy Patients
NCT03008174
Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients
NCT05346263
Facilitating Patient Communication During Noninvasive Ventilation
NCT04912544
Optimizing Communication During Ventilation
NCT01819090
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adaptation of ventilation parameters (mainly triggering sensitivity and use of positive expiratory pressure (PEP)) can significantly improve speech quality and therefore ventilated patients' communication. These adapted parameters are not strictly necessary for ventilation outside of speaking periods. It would be of interest to be able to use them exclusively during speech. In neuromuscular patients, the major motor disability constitutes a challenge as most patients are unable to use themselves the controls of their ventilator (and to potentially switch to a speech adapted ventilation program). We want to evaluate a device able to automatically detect speech and to transitorily switch from the patient's usual ventilation parameters to speech specific parameters set to optimize phonation quality.
Specific adaptations differs between NIV or IVT, therefore we will evaluation two groups of ventilation dependent patients divided according to their ventilation mode.
We believe that this device may improve the speech of NIV patients as well as IVT patients. Patients would benefit from an appropriate ventilator support without any ventilation desynchronization during speech. Speech would be more fluent and natural which would result in improved communication.
Objectives The main objective of this study is to demonstrate that phonation is improved by the use of a device allowing the transitory switch to specific speech parameters of ventilation in neuromuscular ventilator dependent patient whether during NIV or during IMT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional mechanical ventilation
Conventional mechanical ventilation, with patient ventilator usual parameters
No interventions assigned to this group
Adapted mechanical ventilation
Mechanical ventilation with parameters specifically modified to improve speech the effect is evaluated with speech trials during different ventilation conditions
speech trials during different ventilation conditions
ventilator parameters are modified
speech trial
reading duration, vocal flow, intelligibility and voice quality will be evaluated during speech
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
speech trials during different ventilation conditions
ventilator parameters are modified
speech trial
reading duration, vocal flow, intelligibility and voice quality will be evaluated during speech
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Neuromuscular patients with a restrictive respiratory failure without major bulbar involvement.
* Adult patient.
* Ventilator dependancy= ventilation duration of 16h/day or more either with NIV or IMT
* Leak ventilation for IMT patients
* Respiratory autonomy of at leat 1h per day
* Usual ventilation mode : assist control mode (either pressure or volume controlled mode) ou spontaneous breathing mode with target volume
* Stable hemodynamic state
* Signed informed consent
Exclusion Criteria
* Use of cuffed tracheostomy tube
* Inability to read
* Pregnancy
* Protected adults
* Acute respiratory failure
* Hemodynamic instability
* not registered with the social security system
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Investigation Clinique et Technologique 805
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène Prigent, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Raymond Poincaré Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raymond Poincaré hospital
Garches, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A00109-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.